确保行政领导对抗凝血管理计划的承诺

IF 1.3 Q4 PHARMACOLOGY & PHARMACY
Jori E. May M.D., Darren M. Triller Pharm.D., Lauren Inglis Pharm.D., MBA, Anne E. Rose Pharm.D., Vicky DiLorenzo-Agramonte MSN, Allison E. Burnett Pharm.D., Glen T. Schumock Pharm.D., MBA, Ph.D., Scott Kaatz D.O., Geoffrey D. Barnes M.D., M.Sc, Jack E. Ansell M.D.
{"title":"确保行政领导对抗凝血管理计划的承诺","authors":"Jori E. May M.D.,&nbsp;Darren M. Triller Pharm.D.,&nbsp;Lauren Inglis Pharm.D., MBA,&nbsp;Anne E. Rose Pharm.D.,&nbsp;Vicky DiLorenzo-Agramonte MSN,&nbsp;Allison E. Burnett Pharm.D.,&nbsp;Glen T. Schumock Pharm.D., MBA, Ph.D.,&nbsp;Scott Kaatz D.O.,&nbsp;Geoffrey D. Barnes M.D., M.Sc,&nbsp;Jack E. Ansell M.D.","doi":"10.1002/jac5.1936","DOIUrl":null,"url":null,"abstract":"<p>Anticoagulation is a leading cause of medication-related harm. As a result, there is increasing recognition of the importance of the development of anticoagulation stewardship programs to ensure safe and effective anticoagulation use across health care settings. Securing administrative leadership support to build such programs is a necessary first step but is often a significant barrier to implementation. Herein, we present a structured approach to guide providers advocating to leadership for stewardship programs at their institutions. We divide the approach into four phases: (1) Build the foundation, (2) Select stewardship initiatives, (3) Develop implementation plans, and (4) Prepare and present a business plan. Within each phase, we outline specific actions to consider, all leading up to the end goal of creating a compelling business plan to generate administrative leadership buy-in. We also provide resources to promote the understanding of institutional needs as well as broader trends across health systems that influence stewardship program development. Our aim is to provide stewardship advocates with the tools to effectively secure leadership support to facilitate the development of Anticoagulation Stewardship Programs across all health care institutions.</p>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 4","pages":"384-394"},"PeriodicalIF":1.3000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.1936","citationCount":"0","resultStr":"{\"title\":\"Securing administrative leadership commitment for anticoagulation stewardship programs\",\"authors\":\"Jori E. May M.D.,&nbsp;Darren M. Triller Pharm.D.,&nbsp;Lauren Inglis Pharm.D., MBA,&nbsp;Anne E. Rose Pharm.D.,&nbsp;Vicky DiLorenzo-Agramonte MSN,&nbsp;Allison E. Burnett Pharm.D.,&nbsp;Glen T. Schumock Pharm.D., MBA, Ph.D.,&nbsp;Scott Kaatz D.O.,&nbsp;Geoffrey D. Barnes M.D., M.Sc,&nbsp;Jack E. Ansell M.D.\",\"doi\":\"10.1002/jac5.1936\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Anticoagulation is a leading cause of medication-related harm. As a result, there is increasing recognition of the importance of the development of anticoagulation stewardship programs to ensure safe and effective anticoagulation use across health care settings. Securing administrative leadership support to build such programs is a necessary first step but is often a significant barrier to implementation. Herein, we present a structured approach to guide providers advocating to leadership for stewardship programs at their institutions. We divide the approach into four phases: (1) Build the foundation, (2) Select stewardship initiatives, (3) Develop implementation plans, and (4) Prepare and present a business plan. Within each phase, we outline specific actions to consider, all leading up to the end goal of creating a compelling business plan to generate administrative leadership buy-in. We also provide resources to promote the understanding of institutional needs as well as broader trends across health systems that influence stewardship program development. Our aim is to provide stewardship advocates with the tools to effectively secure leadership support to facilitate the development of Anticoagulation Stewardship Programs across all health care institutions.</p>\",\"PeriodicalId\":73966,\"journal\":{\"name\":\"Journal of the American College of Clinical Pharmacy : JACCP\",\"volume\":\"7 4\",\"pages\":\"384-394\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jac5.1936\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American College of Clinical Pharmacy : JACCP\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1936\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.1936","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

抗凝是造成药物相关伤害的主要原因。因此,越来越多的人认识到制定抗凝管理计划的重要性,以确保在各种医疗机构中安全有效地使用抗凝药物。获得行政领导的支持以建立此类计划是必要的第一步,但往往会成为实施的重大障碍。在此,我们提出了一种结构化方法,以指导医疗服务提供者向领导层宣传其所在机构的管理计划。我们将该方法分为四个阶段:(1)建立基础;(2)选择监管计划;(3)制定实施计划;(4)准备并提交业务计划。在每个阶段中,我们都会概述需要考虑的具体行动,所有这些行动都是为了实现最终目标,即制定一份令人信服的业务计划,以获得行政领导层的支持。我们还提供资源,以促进对机构需求的了解,以及对影响监管项目发展的整个医疗系统的更广泛趋势的了解。我们的目标是为抗凝管理倡导者提供有效确保领导层支持的工具,以促进所有医疗机构抗凝管理计划的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Securing administrative leadership commitment for anticoagulation stewardship programs

Securing administrative leadership commitment for anticoagulation stewardship programs

Anticoagulation is a leading cause of medication-related harm. As a result, there is increasing recognition of the importance of the development of anticoagulation stewardship programs to ensure safe and effective anticoagulation use across health care settings. Securing administrative leadership support to build such programs is a necessary first step but is often a significant barrier to implementation. Herein, we present a structured approach to guide providers advocating to leadership for stewardship programs at their institutions. We divide the approach into four phases: (1) Build the foundation, (2) Select stewardship initiatives, (3) Develop implementation plans, and (4) Prepare and present a business plan. Within each phase, we outline specific actions to consider, all leading up to the end goal of creating a compelling business plan to generate administrative leadership buy-in. We also provide resources to promote the understanding of institutional needs as well as broader trends across health systems that influence stewardship program development. Our aim is to provide stewardship advocates with the tools to effectively secure leadership support to facilitate the development of Anticoagulation Stewardship Programs across all health care institutions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信